Chad Hooper

Chad has spent the last decade supporting industry-leading pharma services companies, with a focus on corporate development activities, including leading mergers and acquisitions and venture capital investments, driving partnerships, and establishing and executing multi-year growth strategies. Chad most recently served the clinical research group of Thermo Fisher Scientific as Vice President, Corporate Development and Strategy, joining that business as part of the acquisition of PPD Inc., a leading CRO. Prior to PPD, Chad served in a similar capacity at Patheon Inc., a leading global CDMO. Chad is a graduate of the University of North Carolina at Chapel Hill and began his career in investment banking at SunTrust Robinson Humphrey and then Edgeview Partners.